Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, May 12, 2022
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
[ Thu, May 12th 2022
] - WOPRAI
Wed, May 11, 2022
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
[ Wed, May 11th 2022
] - WOPRAI
Andrew Fein Maintained (STRO) at Strong Buy with Decreased Target to $30 on, May 11th, 2022
Andrew Fein of HC Wainwright & Co., Maintained "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $35 to $30 on, May 11th, 2022.
Andrew, nor any peers, have made any analyst calls on STRO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30